ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,422Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 113

$398K Total Retail Price of All Prescriptions

Rank: 50 out of 113

272 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 272 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 272 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 7,112 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 548 447 1 1
SIMVASTATIN 516 442 2 2
LISINOPRIL 272 195 3 3
AMLODIPINE BESYLATE 244 223 4 4
OMEPRAZOLE 243 198 5 5
POTASSIUM CHLORIDE 219 186 6 12
HYDROCHLOROTHIAZIDE 207 179 7 9
HYDROCODONE-ACETAMINOPHEN 206 157 S3 8 7
WARFARIN SODIUM 177 160 9 8
CITALOPRAM HBR 166 154 10 17
FUROSEMIDE 160 158 11 6
ATENOLOL 159 134 12 16
METOPROLOL SUCCINATE 147 135 13 10
METFORMIN HCL 143 125 14 11
DOXAZOSIN MESYLATE 123 98 15 49
LOSARTAN-HYDROCHLOROTHIAZIDE 120 108 16 40
ALLOPURINOL 115 96 17 20
TAMSULOSIN HCL 110 101 18 24
METOPROLOL TARTRATE 99 96 19 14
LOSARTAN POTASSIUM 91 77 20 13
TRIAMTERENE-HCTZ 87 86 21 26
DIGOXIN 84 84 22 27
SPIRONOLACTONE 82 75 23 32
SPIRONOLACTONE-HCTZ 81 81 24 107
ATORVASTATIN CALCIUM 81 70 24 15
BUMETANIDE 79 76 26 113
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 67 27 34
DONEPEZIL HCL 68 68 28 33
ALENDRONATE SODIUM 68 59 28 22
PRAVASTATIN SODIUM 64 64 30 23
FLUTICASONE PROPIONATE 57 39 31 39
GLIMEPIRIDE 56 27 32 36
AZITHROMYCIN 56 50 32 65
BISOPROLOL FUMARATE 54 54 34 193
CARVEDILOL 53 47 35 25
GABAPENTIN 53 42 35 18
SINGULAIR 52 38 37 121
METOLAZONE 50 41 38 131
PREDNISONE 50 46 38 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 2, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.